Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
- PMID: 39551350
- DOI: 10.1016/j.clnesp.2024.11.011
Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
Abstract
Background & aims: Type 2 diabetes mellitus (T2DM) poses a significant global health challenge due to various lifestyle factors contributing to its prevalence and associated complications. Chronic low-grade inflammation, characterized by elevated levels of inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), plays a pivotal role in the pathogenesis of T2DM. Modulation of the gut microbiota through microbiome-targeted therapy (MTT), including probiotics, prebiotics, and synbiotics, has emerged as a potential strategy to mitigate inflammation and improve metabolic outcomes in T2DM.
Methods: A systematic review and meta-analysis were conducted following PRISMA guidelines to evaluate the impact of MTT on inflammatory markers in patients with T2DM. Searches were performed in PubMed, Scopus, and Web of Science databases up to June 2024, with inclusion criteria limited to English-language meta-analyses of randomized controlled trials (RCTs) assessing the effects of probiotics, prebiotics, or synbiotics on inflammatory markers in T2DM patients.
Results: Ten meta-analyses met the inclusion criteria, comprising studies investigating the effects of various MTT interventions on CRP, IL-6, and TNF-α levels in T2DM patients. Meta-analysis results indicated significant reductions in CRP (SMD: -0.070; 95 % CI: -0.119 to -0.020) and TNF-α (SMD: -0.370; 95 % CI: -0.554 to -0.186) levels following MTT, while IL-6 reductions (SMD: -0.070; 95 % CI: -0.269 to 0.129) did not reach statistical significance. However, heterogeneity in study quality, intervention protocols, and participant demographics posed challenges in interpretation.
Conclusions: While improvements in inflammatory markers with MTT have been observed, significant limitations-such as heterogeneity in study quality and variation in intervention protocols-highlight the need for further research to confirm its efficacy and clarify underlying mechanisms. Future studies should aim to address these limitations by exploring variations in dosage, supplement formulations, and bacterial strains, which are crucial for improving the reliability and broader applicability of MTT in the management of T2DM.
Keywords: CRP; IL-6; Inflammatory markers; Probiotics; TNF-α; Type 2 diabetes mellitus.
Copyright © 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
The Value of Microbiome-targeted Therapy on Lipid Indices of Patients with Type 2 Diabetes Mellitus: An Umbrella Meta-analysis of Randomized Controlled Trials.Curr Diabetes Rev. 2024;21(1):e180124225761. doi: 10.2174/0115733998284844240102110559. Curr Diabetes Rev. 2024. PMID: 38243955
-
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.Diabetologia. 2021 Jan;64(1):26-41. doi: 10.1007/s00125-020-05295-1. Epub 2020 Oct 13. Diabetologia. 2021. PMID: 33047170
-
Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.Trials. 2020 Apr 14;21(1):324. doi: 10.1186/s13063-020-04236-y. Trials. 2020. PMID: 32290852 Free PMC article.
-
Efficacy of probiotic, prebiotic, and synbiotics supplements in individuals with anemia: a systematic review and meta-analysis of randomized controlled trials.BMC Gastroenterol. 2024 Dec 23;24(1):472. doi: 10.1186/s12876-024-03562-8. BMC Gastroenterol. 2024. PMID: 39716076 Free PMC article.
-
The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis.Nutr Rev. 2025 Feb 1;83(2):e4-e24. doi: 10.1093/nutrit/nuae002. Nutr Rev. 2025. PMID: 38341803 Free PMC article.
Cited by
-
Triglyceride-glucose index as a marker in cardiovascular diseases; a bibliometric study and visual analysis.Ann Med Surg (Lond). 2025 Feb 27;87(3):1487-1505. doi: 10.1097/MS9.0000000000003019. eCollection 2025 Mar. Ann Med Surg (Lond). 2025. PMID: 40213252 Free PMC article. Review.
-
Exploring the evolution of evidence synthesis: a bibliometric analysis of umbrella reviews in medicine.Ann Med Surg (Lond). 2025 Feb 26;87(4):2035-2048. doi: 10.1097/MS9.0000000000003034. eCollection 2025 Apr. Ann Med Surg (Lond). 2025. PMID: 40212143 Free PMC article. Review.
-
Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study.Diabetol Metab Syndr. 2025 May 16;17(1):158. doi: 10.1186/s13098-025-01720-w. Diabetol Metab Syndr. 2025. PMID: 40380271 Free PMC article. Review.
-
Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications.Front Pharmacol. 2025 Feb 3;16:1534634. doi: 10.3389/fphar.2025.1534634. eCollection 2025. Front Pharmacol. 2025. PMID: 39963239 Free PMC article. Review.
-
Prevalence of nonalcoholic fatty liver disease in rheumatoid arthritis: An updated systematic review and meta-analysis.Medicine (Baltimore). 2025 Aug 8;104(32):e43641. doi: 10.1097/MD.0000000000043641. Medicine (Baltimore). 2025. PMID: 40797381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous